{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:39:35Z","timestamp":1792723175989,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rare Disease Hong Kong","award":["\/"],"award-info":[{"award-number":["\/"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Literature suggests that rare disease (RD) have adverse effects on patients\u2019 physical and psychosocial well-being. RD patients also face various challenges in their daily lives. This study aims to quantify the impact of RDs on patients in Hong Kong in terms of their sociodemographic characteristics, health-related conditions, patient experience, psychosocial support, illness perception, and self-esteem.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a cross-sectional survey of RD patients in Hong Kong. A mixed-mode survey approach, which included purposive, opportunity, and snowball sampling, was adopted. Participants were recruited through Rare Disease Hong Kong (RDHK) and completed a face-to-face, interviewer-administered survey(\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009176). The 127-item survey instrument covered aspects on sociodemographic characteristics, health-related conditions, patient experience, psychosocial support, illness perception, and self-esteem. Health-related quality of life (HRQL) was assessed using 12-item Short-Form Health Survey version 2 (SF-12 v2), from which a Physical Component Summary was derived for physical health, and a Mental Component Summary for psychological health. Univariate analyses and multivariate linear regression analyses were conducted subsequently to examine the associations between HRQL and sample characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>RD patients in this study were found to have poor physical and psychological HRQL compared with population norms. They also faced challenges and difficulties in their daily lives, including but not limited to economic activities, ability to work, sleep quality, activities of daily living, patient experience, psychosocial support, outlook on life, and self-esteem.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>To our knowledge, this is the first study in Hong Kong that quantifies the impact of RDs on patients\u2019 HRQL, and their experience throughout the disease journey. Due to the multi-faceted impact of RD on their patients, we opine that it is critical to adopt a capability approach that does not merely emphasize on the resourcist right and entitlement of the patients, but also ensures equality in capabilities in converting resources to outcomes they value by focusing on the social determinants of health beyond healthcare policies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04482-4","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:53:01Z","timestamp":1784875981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health and social challenges faced by rare disease patients in Hong Kong: a cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4407-8208","authenticated-orcid":false,"given":"Roger","family":"Yat-Nork Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin","family":"Yik-Kiu Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Ka-Long","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl Shu Ming","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"4482_CR1","unstructured":"EURORDIS. What is a rare disease? [Internet]. Paris: European Organisation for Rare Diseases. 2020. https:\/\/www.eurordis.org\/information-support\/what-is-a-rare-disease\/"},{"issue":"9","key":"4482_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/adc.2010.193664","volume":"96","author":"JA Dodge","year":"2011","unstructured":"Dodge JA, Chigladze T, Donadieu J, et al. The importance of rare diseases: from the gene to society. Arch Dis Child. 2011;96(9):791\u20132.","journal-title":"Arch Dis Child"},{"issue":"2","key":"4482_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap S, Lambert DM, Olry A, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165\u201373.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"4482_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrd3654","volume":"11","author":"I Melnikova","year":"2012","unstructured":"Melnikova I. Rare diseases and orphan drugs. Nat Rev Drug Discov. 2012;11(4):267\u20138. Published 2012 Mar 30.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"4482_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","volume":"18","author":"T Richter","year":"2015","unstructured":"Richter T, Nestler-Parr S, Babela R, et al. Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group. Value Health. 2015;18(6):906\u201314.","journal-title":"Value Health"},{"key":"4482_CR6","unstructured":"European Commission. DG health and food safety. public health. Rare Diseases. [Internet]. 2021. Available from: https:\/\/ec.europa.eu\/health\/non_communicable_diseases\/rare_diseases_en."},{"issue":"9","key":"4482_CR7","doi-asserted-by":"publisher","first-page":"e0204206","DOI":"10.1371\/journal.pone.0204206","volume":"13","author":"JC Hsu","year":"2018","unstructured":"Hsu JC, Wu HC, Feng WC, Chou CH, Lai EC, Lu CY. Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan\u2019s National Health Insurance Research Database. PLoS ONE. 2018;13(9):e0204206. Published 2018 Sep 21.","journal-title":"PLoS ONE"},{"key":"4482_CR8","first-page":"1","volume":"13","author":"ATG Chiu","year":"2018","unstructured":"Chiu ATG, Chung CCY, Wong WHS, Lee SL, Chung BHY. Healthcare burden of rare diseases in Hong Kong - Adopting ORPHAcodes in ICD-10 based healthcare administrative datasets Dr. Segolene Ayme. Orphanet J Rare Dis Orphanet J Rare Dis. 2018;13:1\u20138.","journal-title":"Orphanet J Rare Dis Orphanet J Rare Dis"},{"key":"4482_CR9","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ajmg.a.33380","volume":"152","author":"JS Cohen","year":"2010","unstructured":"Cohen JS, Biesecker BB. Quality of life in rare genetic conditions: A systematic review of the literature. Am J Med Genet Part A. 2010;152:1136\u201356.","journal-title":"Am J Med Genet Part A"},{"key":"4482_CR10","unstructured":"Shire. Rare Disease Impact Report: Insights from patients and the medical community. Rare Dis Impact Rep. 2013."},{"key":"4482_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13023-017-0730-1","volume":"12","author":"KR Bogart","year":"2017","unstructured":"Bogart KR, Irvin VL. Health-related quality of life among adults with diverse rare disorders. Orphanet J Rare Dis. 2017;12:177.","journal-title":"Orphanet J Rare Dis"},{"key":"4482_CR12","first-page":"227","volume":"194","author":"SE Yount","year":"2016","unstructured":"Yount SE, Beaumont JL, Chen SY, Kaiser K, Wortman K, Van Brunt DL, et al. Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis. Lung Springer US. 2016;194:227\u201334.","journal-title":"Lung Springer US"},{"issue":"6","key":"4482_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s11136-012-0269-5","volume":"22","author":"M Calvert","year":"2013","unstructured":"Calvert M, Pall H, Hoppitt T, Eaton B, Savill E, Sackley C. Health-related quality of life and supportive care in patients with rare long-term neurological conditions. Qual Life Res. 2013;22(6):1231\u20138.","journal-title":"Qual Life Res"},{"key":"4482_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jclinepi.2010.04.012","volume":"63","author":"NE Rothrock","year":"2010","unstructured":"Rothrock NE, Hays RD, Spritzer K, Yount SE, Riley W, Cella D. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2010;63:1195\u2013204.","journal-title":"J Clin Epidemiol"},{"key":"4482_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1046\/j.1365-2702.2003.00776.x","volume":"12","author":"B Berglund","year":"2003","unstructured":"Berglund B, Mattiasson AC, Nordstr\u00f6m G. Acceptance of disability and sense of coherence in individuals with Ehlers-Danlos syndrome. J Clin Nurs. 2003;12:770\u20137.","journal-title":"J Clin Nurs"},{"key":"4482_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0211343","volume":"14","author":"N Uhlenbusch","year":"2019","unstructured":"Uhlenbusch N, L\u00f6we B, H\u00e4rter M, Schramm C, Weiler-Normann C, Depping MK. Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study. PLoS ONE. 2019;14:1\u201317.","journal-title":"PLoS ONE"},{"key":"4482_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-016-0409-z","volume":"11","author":"C Molster","year":"2016","unstructured":"Molster C, Urwin D, Di Pietro L, et al. Survey of healthcare experiences of Australian adults living with rare diseases. Orphanet J Rare Dis. 2016;11:30. Published 2016 Mar 24.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"4482_CR18","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41431-024-01604-z","volume":"32","author":"F Faye","year":"2024","unstructured":"Faye F, Crocione C, Anido de Pe\u00f1a R, et al. Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey. Eur J Hum Genet. 2024;32(9):1116\u201326.","journal-title":"Eur J Hum Genet"},{"key":"4482_CR19","unstructured":"Limb L, Nutt S, Sen A. Experiences of Rare Diseases: An Insight from Patients and Families. London, United Kingdom; 2010."},{"key":"4482_CR20","unstructured":"Legislative Council Secretariat. Rare disease policies in selected places. Hong Kong; 2017."},{"key":"4482_CR21","unstructured":"Hospital Authority. Samaritan Fund [Internet]. 2021. Available from: https:\/\/www.ha.org.hk\/visitor\/ha_visitor_index.asp?Content_ID=10048%26=ENG%26Dimension=100%26Parent_ID=10044."},{"key":"4482_CR22","unstructured":"Authority H. Community Care Fund Medical Assistance Programmes [Internet]. 2021. Available from: https:\/\/www.ha.org.hk\/haho\/ho\/ccf\/CCF_e.html."},{"key":"4482_CR23","unstructured":"The Government of the Hong Kong Special Administrative Region. LCQ20: Policies and measures on rare diseases [Internet]. 2021. Available from: https:\/\/www.info.gov.hk\/gia\/general\/202105\/05\/P2021050500461.htm."},{"key":"4482_CR24","unstructured":"Legislative Council Secretariat. Supplementary information on rare disease policies in selected places [Internet]. Hong Kong SAR. 2017. Available from: https:\/\/www.legco.gov.hk\/research-publications\/english\/1617fs06-supplementary-information-on-rare-disease-policies-in-selected-places-20170714-e.pdf."},{"key":"4482_CR25","unstructured":"GovHK. Press, Releases. \u2013 LCQ 21: Treatment of rare diseases [Internet]. 2013. Available from: https:\/\/www.info.gov.hk\/gia\/general\/201307\/10\/P201307100483.htm."},{"key":"4482_CR26","unstructured":"GovHK. LCQ3: Rare diseases. Available from: http:\/\/www.info.gov.hk\/gia\/general\/201307\/10\/P20130%0A7100483.htm."},{"issue":"9","key":"4482_CR27","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.jval.2022.04.1725","volume":"25","author":"YNC Ng","year":"2022","unstructured":"Ng YNC, Ng NYT, Fung JLF, et al. Evaluating the Health-Related Quality of Life of the Rare Disease Population in Hong Kong Using EQ-5D 3-Level. Value Health. 2022;25(9):1624\u201333.","journal-title":"Value Health"},{"key":"4482_CR28","doi-asserted-by":"crossref","unstructured":"O\u2019Connor DJ, Hemmings RJ. Coping with small populations of patients in clinical trials. Expert Opin Orphan Drugs. 2014.","DOI":"10.1517\/21678707.2014.931221"},{"key":"4482_CR29","unstructured":"Rainbow Across Borders. Understanding the impact of rare diseases in Asia: Patient & caregiver survey. 2nd Rare Disease Asia Conference 2016. 2016. Available from: www.rarediseaseasia.org."},{"key":"4482_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1365-2753.2011.01800.x","volume":"19","author":"E Lam","year":"2013","unstructured":"Lam E, Lam C, Fong D, Huang W. Is the SF-12 version 2 Health Survey a valid and equivalent substitute for the SF-36 version 2 Health Survey for the Chinese? J Eval Clin Pract. 2013;19:200\u20138.","journal-title":"J Eval Clin Pract"},{"issue":"1","key":"4482_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12955-020-01653-0","volume":"19","author":"DYT Fong","year":"2021","unstructured":"Fong DYT, Wong JYH, Choi EPH, Lam KF, Kwok C. The English and Chinese language versions of the Short Form 12-item Health Survey are equivalent. Health Qual Life Outcomes. 2021;19(1):14.","journal-title":"Health Qual Life Outcomes"},{"key":"4482_CR32","first-page":"77","volume":"32","author":"C Lam","year":"2010","unstructured":"Lam C, Wong C, Lam ETP, Lo YYC, Huang WW. Population norm of Chinese (HK) SF-12 health survey-version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner. 2010;32:77\u201386.","journal-title":"Hong Kong Practitioner"},{"key":"4482_CR33","first-page":"912","volume-title":"Development of a Chinese version of the Modified Barthel Index \u2014 validity and reliability. Clin Rehabil","author":"SOC Leung","year":"2007","unstructured":"Leung SOC, Chan CCH, Shah S. Development of a Chinese version of the Modified Barthel Index \u2014 validity and reliability. Clin Rehabil. Volume 21. London, England: Sage PublicationsSage UK; 2007. pp. 912\u201322."},{"key":"4482_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1479-8425.2011.00532.x","volume":"10","author":"AML Chong","year":"2012","unstructured":"Chong AML, Cheung CK. Factor structure of a Cantonese-version Pittsburgh Sleep Quality Index. Sleep Biol Rhythms. 2012;10:118\u201325.","journal-title":"Sleep Biol Rhythms"},{"key":"4482_CR35","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2471\/BLT.09.067231","volume":"88","author":"TB \u00dcst\u00fcn","year":"2010","unstructured":"\u00dcst\u00fcn TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88:815\u201323.","journal-title":"Bull World Health Organ"},{"key":"4482_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0191-8869(99)00098-7","volume":"28","author":"KL Chou","year":"2000","unstructured":"Chou KL. Assessing Chinese adolescents\u2019 social support: the multidimensional scale of perceived social support. Pers Individ Dif Pergamon. 2000;28:299\u2013307.","journal-title":"Pers Individ Dif Pergamon"},{"key":"4482_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/13548500500407367","volume":"11","author":"CR Martin","year":"2006","unstructured":"Martin CR, Thompson DR, Chan DS. An examination of the psychometric properties of the Rosenberg Self-Esteem Scale (RSES) in Chinese acute coronary syndrome (ACS) patients. Psychol Health Med Routledge. 2006;11:507\u201321.","journal-title":"Psychol Health Med Routledge"},{"key":"4482_CR38","doi-asserted-by":"publisher","DOI":"10.1515\/9781400876136","volume-title":"Society and the Adolescent Self-Image. Science (80-)","author":"M Rosenberg","year":"1965","unstructured":"Rosenberg M. Society and the Adolescent Self-Image. Science (80-). Princeton, NJ: Princeton University Press; 1965."},{"key":"4482_CR39","unstructured":"Orphanet. Linearisation rules for rare diseases - Procedural document. Paris; 2014."},{"issue":"4","key":"4482_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139.","journal-title":"J Clin Epidemiol"},{"key":"4482_CR41","doi-asserted-by":"publisher","first-page":"101889","DOI":"10.1016\/j.gimo.2024.101889","volume":"2","author":"A Rao","year":"2024","unstructured":"Rao A, Yabumoto M, Ward-Lev E, Miller EG, Naik H, Halley MC. Health-related quality of life in patients with diverse rare diseases: An online survey. Genet Med Open. 2024;2:101889. Published 2024 Aug 15.","journal-title":"Genet Med Open"},{"key":"4482_CR42","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s11136-018-1863-y","volume":"27","author":"RYN Chung","year":"2018","unstructured":"Chung RYN, Chung GKK, Gordon D, Wong SYS, Chan D, Lau MKW, et al. Deprivation is associated with worse physical and mental health beyond income poverty: a population-based household survey among Chinese adults. Qual Life Res. 2018;27:2127\u201335.","journal-title":"Qual Life Res"},{"issue":"Suppl 6","key":"4482_CR43","first-page":"4","volume":"21","author":"CL Lam","year":"2015","unstructured":"Lam CL, Law WL, Poon JT, et al. Health-related quality of life in patients with colorectal neoplasm and cost-effectiveness of colorectal cancer screening in Hong Kong. Hong Kong Med J. 2015;21(Suppl 6):4\u20138.","journal-title":"Hong Kong Med J"},{"issue":"1 Pt 1","key":"4482_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2869.2010.00822.x","volume":"20","author":"WS Wong","year":"2011","unstructured":"Wong WS, Fielding R. Prevalence of insomnia among Chinese adults in Hong Kong: a population-based study. J Sleep Res. 2011;20(1 Pt 1):117\u201326.","journal-title":"J Sleep Res"},{"issue":"8","key":"4482_CR45","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/gps.1158","volume":"19","author":"ES Chow","year":"2004","unstructured":"Chow ES, Kong BM, Wong MT, et al. The prevalence of depressive symptoms among elderly Chinese private nursing home residents in Hong Kong. Int J Geriatr Psychiatry. 2004;19(8):734\u201340.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"20","key":"4482_CR46","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3109\/09638288.2014.989336","volume":"37","author":"MK Cheung","year":"2015","unstructured":"Cheung MK, Hung AT, Poon PK, et al. Validation of the World Health Organization Assessment Schedule II Chinese Traditional Version (WHODAS II CT) in persons with disabilities and chronic illnesses for Chinese population. Disabil Rehabil. 2015;37(20):1902\u20137.","journal-title":"Disabil Rehabil"},{"key":"4482_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1037\/a0028931","volume":"139","author":"JF Sowislo","year":"2013","unstructured":"Sowislo JF, Orth U. Does low self-esteem predict depression and anxiety? A meta-analysis of longitudinal studies. Psychol Bull. 2013;139:213\u201340.","journal-title":"Psychol Bull"},{"key":"4482_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/1745017901006010025","volume":"6","author":"C Conversano","year":"2010","unstructured":"Conversano C, Rotondo A, Lensi E, Della Vista O, Arpone F, Reda MA. Optimism and Its Impact on Mental and Physical Well-Being. Clin Pract Epidemiol Ment Heal. 2010;6:25\u20139.","journal-title":"Clin Pract Epidemiol Ment Heal"},{"issue":"11","key":"4482_CR49","doi-asserted-by":"publisher","first-page":"e0205794","DOI":"10.1371\/journal.pone.0205794","volume":"13","author":"SY Wong","year":"2018","unstructured":"Wong SY, Chung RY, Chan D, et al. What are the financial barriers to medical care among the poor, the sick and the disabled in the Special Administrative Region of China? PLoS ONE. 2018;13(11):e0205794. Published 2018 Nov 14.","journal-title":"PLoS ONE"},{"issue":"2","key":"4482_CR50","first-page":"97","volume":"80","author":"A Wagstaff","year":"2002","unstructured":"Wagstaff A. Poverty and health sector inequalities. Bull World Health Organ. 2002;80(2):97\u2013105.","journal-title":"Bull World Health Organ"},{"key":"4482_CR51","unstructured":"Organisation for Economics Co-operation and Developemtn (OECD). DAC Guidelines and Reference Series: Poverty and Health. 2003."},{"key":"4482_CR52","unstructured":"The World Bank. Poverty and Health [Internet]. 2014. Available from: https:\/\/www.worldbank.org\/en\/topic\/health\/brief\/poverty-health."},{"key":"4482_CR53","unstructured":"Food and Health Bureau. Health Reform\u2013Second Stage Public Consultation. My Health My Choice. Hong Kong; 2010."},{"key":"4482_CR54","unstructured":"Rare Diseases International. Rare Diseases: Leaving No One Behind in Universal Health Coverage. EURORDIS-Rare Diseases Europe. 2019. Accessed [April 1, 2026]. https:\/\/www.eurordis.org\/publications\/rare-diseases-international-leaving-no-one-behind-in-universal-health-coverage\/."},{"key":"4482_CR55","unstructured":"Kao E, Tsang E. Hong Kong government urged to subsidise drugs for patients with rare genetic diseases. South China Morning Post [Internet]. 2017; Available from: https:\/\/www.scmp.com\/news\/hong-kong\/health-environment\/article\/2092352\/hong-kong-government-urged-subsidise-drugs."},{"key":"4482_CR56","unstructured":"The Government of the Special Administrative Region of Hong Kong. LCQ17: Samaritan Fund and Community Care Fund Medical Assistance Programmes [Internet]. 2019. Available from: https:\/\/www.info.gov.hk\/gia\/general\/201901\/30\/P2019013000681.htm"},{"key":"4482_CR57","unstructured":"Sun C. Healthcare reform in Hong Kong: supplementary financing in a mixed healthcare economy [Master\u2019s thesis\/Doctoral dissertation]. The University of Hong Kong. HKU Scholars Hub;2013."},{"key":"4482_CR58","first-page":"371","volume":"18","author":"ELY Wong","year":"2012","unstructured":"Wong ELY, Coulter A, Cheung AWL, Yam CHK, Yeoh EK, Griffiths SM. Patient experiences with public hospital care: First benchmark survey in Hong Kong. Hong Kong Med J. 2012;18:371\u201380.","journal-title":"Hong Kong Med J"},{"key":"4482_CR59","unstructured":"Our Hong Kong Foundation. Fit for Purpose: A Health System for the 21st Century [Internet]. 2018. Available from: https:\/\/www.ourhkfoundation.org.hk\/sites\/default\/files\/media\/pdf\/ohkf_research_report_digital_1201.pdf."},{"key":"4482_CR60","unstructured":"Solar O, Irwin A. A conceptual framework for action on the social determinants of health. Social Determinants of Health Discussion Paper 2 (Policy and Practice) [Internet]. 2010. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44489\/?sequence=1."},{"key":"4482_CR61","unstructured":"Sen A. Equality of what? The Tanner Lecture on Human Values. Contemp. Polit. Theory A Read. 1979."},{"key":"4482_CR62","volume-title":"Development as Freedom. 1st","author":"A Sen","year":"1999","unstructured":"Sen A. Development as Freedom. 1st. ed. New York: Anchor Books; 1999."},{"key":"4482_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/0198287976.001.0001","volume-title":"The Quality of life","author":"M Nussbaum","year":"1993","unstructured":"Nussbaum M, Sen A. The Quality of life. Oxford [England]: Clarendon; 1993."},{"key":"4482_CR64","unstructured":"World Health Organization. Rare diseases: a global health priority for equity and inclusion. Resolution WHA78.11. May 2025. Accessed April 1, 2026. https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/WHA78\/A78_R11-en.pdf."},{"key":"4482_CR65","unstructured":"United Nations General Assembly. Addressing the challenges of persons living with a rare disease and their families. Resolution A\/RES\/78\/173. December 19, 2023. Accessed April 1. 2026. https:\/\/docs.un.org\/en\/A\/RES\/78\/173."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04482-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04482-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04482-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:23:51Z","timestamp":1792722231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04482-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4482"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04482-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Survey and Behavioral Research Ethics Committee of the Chinese University of Hong Kong.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"371"}}